Recro Pharma Cash Flow - Quarterly (NASDAQ:REPH)

Add to My Stocks
$7.5 $0.09 (1.21%) REPH stock closing price Sep 19, 2018 (Closing)

For analyzing any company like Recro Pharma from an investment perspective, its important to check the cash flow statement. While its important to look at the Recro Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Recro Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Recro Pharma stock analysis. Recro Pharma generated $-24.24M cash from operating activities in till this quarter of 2018 Q2. REPH decrease in investments stood at a value of $- for the latest quarter 2018 Q2.

View and download details of Recro Pharma cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-25.17M-12.45M-50.08M-25.99M-16.94M-8.08M-30.2M-19.8M-14.42M-6.53M
Depreciation Depletion Amortization Cash-Flow3.79M1.86M7.44M5.59M3.71M1.84M7.57M5.69M3.8M1.91M
Net Increase (Decrease) in Assets Liabilities-4.29M-7.04M--7.91M-3.48M-3.81M6.53M-1.08M--
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.43M2.84M25.15M10.28M5.72M2.92M12.89M10.99M5.03M1.97M
Net Cash from (used by) Operating Activities
-24.24M-14.79M-17.04M-18.04M-10.98M-7.13M-3.2M-4.19M-5.39M-2.44M
Increase (Decrease) in Prop Plant And Equipment-2.93M-1.65M-6.17M-4.58M-3.18M-1.74M-3.77M-2.01M-1.08M-0.34M
Acquisition Disposition of Subsidiaires-0.08M--0.51M-0.43M-0.01M-----
Increase (Decrease) in Investments3.52M-1.48M-3.62M-29.62M-41.59M-36.11M----
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
--3.13M-10.31M-34.64M-44.79M-37.86M-3.77M-2.01M-1.08M-0.34M
Issuance (Purchase) of Equity Shares12.01M3.57M----50.25M17.54M4.17M-
Issuance (Repayment) of Debt Securities--32.65M----6.32M-6.32M-2.63M-2.63M
Increase (Decrease) in Bank & Other Borrowings------7.79M---
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.35M-0.34M-8.84M-0.01M---0.05M-0.03M--
Net Cash from (used by) Financing Activities
11.66M3.23M23.85M---51.67M11.18M1.54M-2.07M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-12.07M-14.7M-3.49M-52.68M-55.75M-44.99M44.7M4.97M-4.93M-4.86M
Cash & Equivalents at Beginning of Year60.98M64.48M19.77M19.68M------
Cash & Equivalents at Year End48.91M46.28M60.98M11.8M8.72M19.48M64.48M24.75M14.84M14.91M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our AcelRx Pharma financial analysis

Recro Pharma stock comparison chart provides an easy way to compare the stock price with peers along with details of Recro Pharma stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Recro Pharma saw a positive change in Net Change in Cash and Cash Equivalents of $-12.07M till 2018 Q2. Apart from the Recro Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Recro Pharma lost $-24.24M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $- for REPH stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $11.66M for Recro Pharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Recro Pharma Cash Flow

Quarterly Cash Flow Statements For Recro Pharma Inc Peers

AcelRx Pharma cash flow, MediWound cash flow, Pernix Therapeutics cash flow, Trevena cash flow